Cannabinoids in multiple sclerosis: A neurophysiological analysis.

Domizia VecchioClaudia VarrasiEleonora VirgilioAntonio SpagarinoPaola NaldiRoberto Cantello

Published in: Acta neurologica Scandinavica (2020)

The THC-CBD spray improved spasticity and pain in secondary progressive MS patients. The spray prolonged CSP duration, which appears a promising tool for assessing and monitoring the analgesic effects of THC-CBD in MS.

Keyphrases

multiple sclerosis
end stage renal disease
mass spectrometry
neuropathic pain
ms ms
ejection fraction
white matter
newly diagnosed
chronic kidney disease
chronic pain
spinal cord injury
prognostic factors
pain management
peritoneal dialysis
spinal cord